Rectal cancer
Conditions
Interventions
Robotic surgery group:Total Mesorectal Excision by Robot-Assisted Methods for the Treatment of Rectal Cancer
Laparoscopy surgery :Total Mesorectal Excision by laparoscopy-Assisted Methods for the Treatment of Rectal Cancer
Sponsors
The First Affiliated Hospital, the Third Military Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients who are acceptable to two surgical procedures for the robot-assisted or laparoscopy-assisted rectal cancer, are willing to randomized trial; 2. Matching the diagnostic criteria; 3. Aged 18-70 years old; 4. Preoperative TNM staging (CT, laparoscopic exploration): cT1-3N0-3M0 (excluding M1, T4); 5. Preoperative ASA 3 scores; 6. There was no history of malignancy, no other malignant tumors by preoperative examination; 7. Without undergoing definitive treatment, such as radiotherapy, chemotherapy or immunotherapy preoperatively; 8. The informed consent form was signed by the patient himself(herself)or his principal agent; 9. In accordance with the international erectile function questionnaire (IIEF) urinary function scale, The urinary sexual function are normal.
Exclusion criteria
Exclusion criteria: 1. Age less than 18 years old or more than 70 years old; 2. Previous psychiatric patients or patients refused to sign the informed consent; 3. Attending other related clinical studies on surgical treatment of rectal cancer; 4. The patient has a history of malignant tumor, or a combination of other malignant tumors; 5. Patients have been treated with definitive treatment: radiotherapy, chemotherapy or immunotherapy; 6. Patients had received otherper abdominal operations (except for laparoscopic cholecystectomy); 7. ASA >3; 8. Laparoscopic surgical contraindications: such as severe heart lung disease; abdominal wall hernia; diaphragmatic hernia; coagulation disorder; portal hypertension; pregnancy, etc.; 9. Those who has been confirmed to be unable to do a radical resection (T4 stage) for local advanced tumor; 10. Those who have urination sexual dysfunction preoperatively.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The overall efficiency of urination function;The overall efficiency of sexual function;Sphincter-preserving rate of low rectal cancer; | — |
Countries
China
Contacts
Public ContactTang Bo
Outcome results
None listed